[HTML][HTML] Malaria medicines: a glass half full?

TNC Wells, RH Van Huijsduijnen… - Nature Reviews Drug …, 2015 - nature.com
Despite substantial scientific progress over the past two decades, malaria remains a
worldwide burden that causes hundreds of thousands of deaths every year. New, affordable …

[HTML][HTML] New developments in anti-malarial target candidate and product profiles

JN Burrows, S Duparc, WE Gutteridge… - Malaria journal, 2017 - Springer
A decade of discovery and development of new anti-malarial medicines has led to a
renewed focus on malaria elimination and eradication. Changes in the way new anti …

New medicines to improve control and contribute to the eradication of malaria

TNC Wells, PL Alonso, WE Gutteridge - Nature reviews Drug discovery, 2009 - nature.com
Despite being one of the most prevalent tropical diseases, for many years malaria was not a
commercial priority for the pharmaceutical industry. However, in response to the emergence …

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

AEI Proudfoot, TM Handel, Z Johnson… - Proceedings of the …, 2003 - National Acad Sciences
During organogenesis, immunosurveillance, and inflammation, chemokines selectively
recruit leukocytes by activating seven-transmembrane-spanning receptors. It has been …

Alcohol use and alcohol-related problems before and after military combat deployment

IG Jacobson, MAK Ryan, TI Hooper, TC Smith… - Jama, 2008 - jamanetwork.com
Context High rates of alcohol misuse after deployment have been reported among
personnel returning from past conflicts, yet investigations of alcohol misuse after return from …

[HTML][HTML] Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

CR Freed, RE Breeze, NL Rosenberg… - … England Journal of …, 1992 - Mass Medical Soc
Abstract Background and Methods. Patients with Parkinson's disease tend to have a
reduced response to levodopa after 5 to 20 years of therapy, with" on—off" fluctuations …

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist

G Simmons, PR Clapham, L Picard, RE Offord… - Science, 1997 - science.org
The chemokine receptors CXCR4 and CCR5 have recently been shown to act as
coreceptors, in concert with CD4, for human immunodeficiency virus–type 1 (HIV-1) …

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness

JA Gonzalo, CM Lloyd, D Wen, JP Albar… - The Journal of …, 1998 - rupress.org
The complex pathophysiology of lung allergic inflammation and bronchial
hyperresponsiveness (BHR) that characterize asthma is achieved by the regulated …

[HTML][HTML] CD4-independent infection by HIV-2 is mediated by fusin/CXCR4

MJ Endres, PR Clapham, M Marsh, M Ahuja, JD Turner… - Cell, 1996 - cell.com
Several members of the chemokine receptor family have been shown to function in
association with CD4 to permit HIV-1 entry and infection. However, the mechanism by which …

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus

TN Kledal, MM Rosenkilde, F Coulin, G Simmons… - Science, 1997 - science.org
Kaposi's sarcoma–associated herpesvirus encodes a chemokine called vMIP-II. This protein
displayed a broader spectrum of receptor activities than any mammalian chemokine as it …